Table 1.
Variables | Treated with BCLT | Untreated with BCLT | P value |
---|---|---|---|
Patients, (N) | 51 | 39 | |
Age (yr) | 67.5 ± 5.5 | 65.2 ± 7.9 | 0.0039a |
PSA at biopsy (ng/ml) | 5.7 ± 5.1 | 6.4 ± 4.8 | 0.107a |
Gleason score at biopsy | |||
≤6 | 29/51 (56.9%) | 20/39 (51.3%) | 0.753b |
7 | 19/51 (37.2) | 17/39 (43.6%) | 0.691b |
8–10 | 3/51 (5.9%) | 2/39 (5.1%) | 0.764b |
Gleason score at radical prostatectomy | |||
≤6 | NA | 17/39 (43.6%) | |
7 | NA | 19/39 (48.8%) | |
8–10 | NA | 3/39 (7.7%) | |
Pathological stage (TNM 2002) | |||
pT2 | 14/51 (27.4%) | 16/39 (41.0%) | 0.258b |
pT3 | 34/51 (66.7) | 20/39 (51.3%) | 0.207b |
pT4 | 3/51 (5.9%) | 3/39 (7.7%) | 0.931b |
NA, Not assessable.
Unpaired Student's t test.
χ2 test.